Distillate US Fundamental Stability & Value ETF
DSTL

$54.31

0.86%

Market Cap: $1.96B

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

156% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 27

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

9.01% more ownership

Funds ownership: 63.82% [Q1] → 72.82% (+9.01%) [Q2]

5% more funds holding

Funds holding: 117 [Q1] → 123 (+6) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 18 [Q1] → 18 (+0) [Q2]

1% less capital invested

Capital invested by funds: $1.39B [Q1] → $1.37B (-$20.2M) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for DSTL.

See Analyst Rankings

Financial journalist opinion

DSTL: Solid Returns For This ETF That Couples Quality And Value

DSTL ETF filters out lower-quality companies based on financial measures and primarily uses free cash flow to gauge valuations. Portfolio consists of stable businesses in healthcare and industrial sectors, avoiding mega caps. DSTL has performed on par with benchmarks over the past 5 years, offering diversification and reasonable valuations without lower-quality companies.

DSTL: Solid Returns For This ETF That Couples Quality And Value

DSTL: A Great Fund Focused On The Right Thing

Distillate U.S. Fundamental Stability & Value ETF is a fund focused on cash flow generation, screening for stable, profitable companies with low debt ratios and attractive valuations. The DSTL fund holds about 100 large-cap US stocks, with a diverse sector mix and top positions in Health Care, offering a different dynamic from passive benchmarks. DSTL has outperformed similar funds in the past two years, but the active approach may not continue to outperform in all market conditions.

DSTL: A Great Fund Focused On The Right Thing

DSTL: Actively-Managed U.S. Value ETF, Cheap Valuation, Strong Performance Track-Record

DSTL is an actively-managed U.S. value ETF. It focuses on large-cap blue-chips, think Johnson & Johnson or AbbVie. The fund is cheaper than the S&P 500, and has outperformed since inception too, unlike most of its value peers.

DSTL: Actively-Managed U.S. Value ETF, Cheap Valuation, Strong Performance Track-Record

DSTL: Distillation At A Price

The Distillate U.S. Fundamental Stability & Value ETF aims to provide investors with exposure to undervalued stocks with stable cash flows. The ETF uses a proprietary algorithm to select stocks based on fundamental stability and value factors. Though it has outperformed the market since its inception in 2018, interested investors should consider the long-term implications.

DSTL: Distillation At A Price

DSTL: With A Solid Share Of Holdings Replaced, This FCF Strategy Remains A Buy

DSTL, an actively managed vehicle focused on top-quality U.S. stocks with copious free cash flows, has reconstituted its portfolio since my December note. DSTL has become more attractive from a valuation standpoint, with quality definitely remaining robust. Unfortunately, there is something to dislike about growth. I am of the opinion that there are ample reasons for a Buy rating.

DSTL: With A Solid Share Of Holdings Replaced, This FCF Strategy Remains A Buy

DSTL: An Alpha-Generating ETF Positioned To Gain Significantly

DSTL is an actively managed FCF-focused ETF, prioritizing fundamental stability and value. DSTL has an exceedingly convincing performance track record, as it beat IVV in 33 out of 61 of its full trading months since its launch in October 2018. There is a solid factor mix under the hood, with a plethora of adequately valued, cash-rich names with low leverage and impressive capital efficiency.

DSTL: An Alpha-Generating ETF Positioned To Gain Significantly

See News Rankings